The PTAB Power Play: How the Federal Circuit Just Made Patent Challenges Harder for Big Tech

The Federal Circuit Doubles Down on USPTO Discretion

The Federal Circuit delivered a significant blow to technology companies challenging patents at the Patent Trial and Appeal Board, rejecting Apple and Google's latest attempt to overturn the USPTO's expanded discretionary denial framework for inter partes review proceedings. The February 13 decision in Apple Inc. v. Vidal preserves the agency's controversial internal rule giving PTAB judges broader authority to deny IPR petitions—even when they meet statutory requirements—based on factors like parallel district court litigation and resource constraints.

This isn't just another procedural skirmish. The ruling fundamentally reshapes the strategic calculus for accused infringers, particularly in the tech sector, who have relied on IPRs as a cost-effective alternative to district court invalidity defenses since the America Invents Act created the proceedings in 2011.

The NHK-Fintiv Framework Survives

At issue is the USPTO's application of the so-called NHK-Fintiv rule, named after two 2019 PTAB decisions that established six factors for discretionary denial under 35 U.S.C. § 314(a). The rule permits the Board to deny institution when parallel district court litigation is addressing the same patent and validity issues, considering factors like trial date proximity and investment in the parallel proceeding.

Apple and Google argued the USPTO lacked statutory authority to deny meritorious petitions based on these considerations, contending that Congress designed IPRs as an alternative to litigation, not a supplement to be rationed at the agency's convenience. The Federal Circuit disagreed, affirming that the Director's rulemaking authority under the AIA encompasses such discretionary frameworks.

The practical effect is stark: a defendant facing infringement claims in the rocket docket of the Eastern District of Texas or the Western District of Texas—where judges routinely set aggressive trial dates—may find the courthouse door to the PTAB slammed shut, forced to litigate validity before a jury rather than technical patent judges.

What This Means for Patent Litigation Strategy

The decision creates immediate tactical challenges for defense counsel. Under the current regime, the timing of an IPR petition relative to district court case schedules has become outcome-determinative. File too late, and the PTAB will likely deny institution under Fintiv factor two (proximity of trial date). File early, and you may lack sufficient discovery to craft the strongest invalidity case.

More fundamentally, the ruling accelerates a troubling trend: the migration of patent validity determinations from specialized administrative judges to generalist juries. The AIA was designed, in part, to provide a technically sophisticated forum for challenging weak patents. By blessing broad discretionary denials, the Federal Circuit has effectively endorsed a system where access to that forum depends on the happenstance of district court scheduling orders.

For patent owners—particularly non-practicing entities—the decision is a windfall. It raises the cost and risk of challenging patents, potentially increasing settlement leverage. Expect to see more aggressive forum shopping by plaintiffs seeking districts with fast trial dates, knowing that doing so may insulate their patents from PTAB scrutiny.

The Broader Administrative Law Context

The ruling also reflects the Federal Circuit's increasingly deferential posture toward USPTO administrative action. Coming on the heels of United States v. Arthrex, Inc., 594 U.S. ___ (2021), which preserved PTAB authority while addressing Appointments Clause concerns, this decision suggests the court is reluctant to second-guess how the agency manages its docket.

That deference is notable given the stakes. IPRs have invalidated claims in roughly 65% of final written decisions, according to USPTO statistics—far exceeding district court invalidation rates. By allowing the agency to limit access to this forum based on resource considerations and parallel litigation, the court has effectively endorsed a two-tiered system where some accused infringers get administrative review and others don't, based on factors unrelated to patent validity.

Looking Ahead: Legislative or Judicial Fix?

The ball now sits in Congress's court. The PREVAIL Act and other proposed legislation would limit or eliminate discretionary denials, but prospects for passage remain uncertain. Meanwhile, expect continued challenges under the Administrative Procedure Act, with petitioners arguing that blanket application of Fintiv factors constitutes arbitrary and capricious agency action.

For now, practitioners must adapt to a new reality: IPRs are no longer a reliable fallback for defendants facing patent claims in fast-moving districts. The strategic imperative is early, aggressive filing—ideally before a district court trial date is set—or a renewed focus on district court invalidity defenses, with all the cost and uncertainty that entails.

The Federal Circuit's decision may bring administrative efficiency to the PTAB, but it comes at a cost: reduced access to the very forum Congress created to improve patent quality. Whether that tradeoff serves the patent system's broader goals remains an open—and increasingly urgent—question.